Manufacturer of the CO₂ Cryoshock Therapy Device CRYOLIGHT® for Medicine and Sport
ELMAKO GmbH & Co. KG
Iffezheim, Industriestraße 8 · 76473 (Development, Manufacturing, Sales)New on Amplifa
About ELMAKO
ELMAKO GmbH & Co. KG, based in Iffezheim (Baden-Württemberg), develops and manufactures the medical device CRYOLIGHT®, a device for neuroreflexive hyperbaric CO₂ cryotherapy (cryoshock therapy). Medical CO₂ gas is directed onto the skin via a nozzle at −78 °C and 0.3 bar, cooling the treated area to 0–4 °C within seconds. The effects are pain-relieving, anti-inflammatory, decongestant, and muscle-relaxing. The patented device features a temperature sensor with automatic shut-off for protection against skin necrosis, battery operation, a color display, and a portable unit with a net weight of 12 kg. CRYOLIGHT® is used in doctor's offices, physiotherapy practices, clinics, and rehabilitation facilities, primarily in sports medicine, orthopedics, accident surgery, dermatology, dentistry, and pain therapy. ELMAKO offers consultation, demonstrations, a two-week free trial, as well as instruction, and sells or rents the devices.
- Site
- Iffezheim
- Processes
- Sale and Leasing/Rental of CRYOLIGHT® Devices, Free Consultation and Demonstration, 2-week Free Trial in Practice/Clinic, User Instruction/Training
- Materials
- Medical CO₂ Gas
- Certificates
- Medical Device (patented)
- Industries
- Medical Technology, Sports Medicine, Orthopedics, Physiotherapy, Dermatology, Dentistry
- 01
Development
- 02
Manufacturing in Iffezheim
- 03
Consultation and Demonstration
- 04
Sale/Leasing
- 05
User Training
Technology and Principle of Action
Medical CO₂ Gas
Coolant that generates the cryoshock on the skin using a nozzle at −78 °C and 0.3 bar.
Location
Iffezheim
DEDevelopment, Manufacturing, Sales
- Materials
- CRYOLIGHT® CO₂ Cryotherapy Devices
Devices
Inside the production
Industries
Additional services
Reference customers
Quality and Safety
The patented device is equipped with a temperature sensor and an automatic shut-off function, which automatically stops the treatment if the skin becomes too cold, thus preventing skin necrosis and burns. Two gas cylinders per device ensure availability on the day of treatment.
| Evidence | Iffezheim |
|---|---|
| Medical Device (patented) |
History
- bis ca. 2010
Established in the medical sector as a manufacturer of a cold therapy device for over 15 years; CRYOLIGHT® has been manufactured for approx. 12 years (exact founding year not specified)
- 2015
Start of reporting and cooperation on neuroreflexive hyperbaric CO₂ cryotherapy with the sportärztezeitung
- 2021
ELMAKO GmbH & Co. KG listed as an application partner on sportaerztezeitung.com
- 2024
CRYOLIGHT® referred to as the exclusive sports medicine partner of the sportärztezeitung